Investor Overview Press Releases November 12, 2019 Aclaris Therapeutics to Present at Upcoming Investor Conferences November 7, 2019 Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights and an Update on R&D Programs October 31, 2019 Aclaris Therapeutics to Announce Third Quarter 2019 Financial Results on November 7, 2019 View all » Events Dec 4, 20193:05 PM EST Aclaris Therapeutics, Inc. at Evercore ISI 2nd Annual HealthCONx Conference Nov 7, 20195:00 PM EST Q3 2019 Aclaris Therapeutics Inc. Earnings Conference Call Oct 24, 20194:30 PM EDT Aclaris Therapeutics Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-1) View all » Feature presentation More presentations coming soon.
November 7, 2019 Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights and an Update on R&D Programs
October 31, 2019 Aclaris Therapeutics to Announce Third Quarter 2019 Financial Results on November 7, 2019
Oct 24, 20194:30 PM EDT Aclaris Therapeutics Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-1)
